This diagnostic study examines the use of RO948 F 18 in tau positron emission tomographic imaging as a diagnostic marker for identification of Alzheimer disease compared with magnetic resonance imaging and cerebrospinal fluid measures. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.